Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Invesco India ELSS Tax Saver Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹107.93 |
| 12 Apr 2015 | ₹190.10 |
| 31 May 2016 | ₹189.39 |
| 19 Jul 2017 | ₹239.80 |
| 07 Sep 2018 | ₹292.22 |
| 27 Oct 2019 | ₹290.66 |
| 15 Dec 2020 | ₹345.81 |
| 03 Feb 2022 | ₹483.84 |
| 25 Mar 2023 | ₹426.57 |
| 12 May 2024 | ₹635.96 |
| 01 Jul 2025 | ₹761.72 |
| 20 Aug 2026 | ₹774.04 |
| Metric | Invesco · Direct NAV ₹153.26 Very High risk ★★☆☆☆ | Category median ELSS · 51 funds |
|---|---|---|
| +2.95% | +3.05% | |
| +14.64% | +14.46% | |
| +11.94% | +13.60% | |
| +14.16% | +13.74% | |
| +16.20% | +14.97% | |
| +12.34% | — | |
| +16.65% | +16.84% | |
| +16.17% | +17.15% | |
| +16.27% | +15.41% | |
| Risk | ||
| 14.69% | 14.19% | |
| 0.55 | 0.52 | |
| 0.75 | 0.70 | |
| -35.82% | -35.94% | |
| Nifty 500 | — | |
| +2.25% | +1.57% | |
| 1.03 | 0.97 | |
| 108.6% | 102.3% | |
| 99.5% | 93.6% | |
| 1.18% | 1.06% | |
| ₹2,546Cr | ₹765.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 21% | 34% | |
| Depesh Kashyap · 1.1y | — | |
| 02 Jan 2013 | — | |
| 71 | — | |
| 24.5% | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.